Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer

被引:0
|
作者
Zoe K. Price
Noor A. Lokman
Mai Sugiyama
Yoshihiro Koya
Masato Yoshihara
Martin K. Oehler
Hiroaki Kajiyama
Carmela Ricciardelli
机构
[1] The University of Adelaide,Reproductive Cancer Group, Discipline of Obstetrics and Gynaecology, Adelaide Medical School, Robinson Research Institute, Adelaide Health and Medical Sciences Building
[2] Nagoya University Graduate School of Medicine,Department of Obstetrics and Gynecology
[3] Nagoya University Graduate School of Medicine,Department of Obstetrics and Gynecology Collaborative Research, Bell Research Center
[4] Royal Adelaide Hospital,Department of Gynaecological Oncology
来源
关键词
Disabled-2; Hyaluronan; Notch3; Metastasis; Prognosis; EMT;
D O I
暂无
中图分类号
学科分类号
摘要
Although the pro-tumorigenic functions of hyaluronan (HA) are well documented there is limited information on the effects and targets of different molecular weight HA. Here, we investigated the effects of 27 kDa, 183 kDa and 1000 kDa HA on ES-2 ovarian cancer cells overexpressing the stem cell associated protein, Notch3. 1000 kDA HA promoted spheroid formation in ES-2 cells mixed with ES-2 overexpressing Notch3 (1:3). We report disabled-2 (DAB2) as a novel protein regulated by 1000 kDa HA and further investigated its role in ovarian cancer. DAB2 was downregulated in ovarian cancer compared to normal tissues but increased in metastatic ovarian tumors compared to primary tumors. High DAB2 expression was associated with poor patient outcome and positively correlated with HA synthesis enzyme HAS2, HA receptor CD44 and EMT and macrophage markers. Stromal DAB2 immunostaining was significantly increased in matched ovarian cancer tissues at relapse compared to diagnosis and associated with reduced survival. The proportion of DAB2 positive macrophages was significantly increased in metastatic ovarian cancer tissues compared to primary cancers. However, DAB2 overexpression significantly reduced invasion by both A2780 and OVCAR3 cells in vivo. Our research identifies a novel relationship between HA signalling, Notch3 and DAB2. We highlight a complex relationship of both pro-tumorigenic and tumor suppressive functions of DAB2 in ovarian cancer. Our findings highlight that DAB2 has a direct tumor suppressive role on ovarian cancer cells. The pro-tumorigenic role of DAB2 may be mediated by tumour associated macrophages and requires further investigation.
引用
收藏
相关论文
共 6 条
  • [1] Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer
    Price, Zoe K.
    Lokman, Noor A.
    Sugiyama, Mai
    Koya, Yoshihiro
    Yoshihara, Masato
    Oehler, Martin K.
    Kajiyama, Hiroaki
    Ricciardelli, Carmela
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (11)
  • [2] Transcriptional coactivator Drosophila Eyes Absent Homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth
    Zhang, L
    Yang, N
    Huang, J
    Buckanovich, RJ
    Liang, S
    Barchetti, A
    Vezzani, C
    O'Brien-Jenkins, A
    Wang, J
    Ward, MR
    Courreges, MC
    Fracchioli, S
    Medina, A
    Katsaros, D
    Weber, BL
    Coukos, G
    CANCER RESEARCH, 2005, 65 (03) : 925 - 932
  • [3] The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia
    Krejci, Pavel
    Pejchalova, Katerina
    Rosenbloom, Barry E.
    Rosenfelt, Fred P.
    Tran, Elizabeth L.
    Laurell, Henrik
    Wilcox, William R.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (06) : 1363 - 1364
  • [4] Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat shock protein 90 (Hsp90) inhibition
    Hackl, Christina
    Moser, Christian
    Lang, Sven
    Stengel, Kathrin
    Schlitt, Hans
    Geissler, Edward
    Stoeltzing, Oliver
    CANCER RESEARCH, 2009, 69
  • [5] Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition
    Christina Hackl
    Sven A Lang
    Christian Moser
    Akira Mori
    Stefan Fichtner-Feigl
    Claus Hellerbrand
    Wolfgang Dietmeier
    Hans J Schlitt
    Edward K Geissler
    Oliver Stoeltzing
    BMC Cancer, 10
  • [6] Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition
    Hackl, Christina
    Lang, Sven A.
    Moser, Christian
    Mori, Akira
    Fichtner-Feigl, Stefan
    Hellerbrand, Claus
    Dietmeier, Wolfgang
    Schlitt, Hans J.
    Geissler, Edward K.
    Stoeltzing, Oliver
    BMC CANCER, 2010, 10